CRSP Total Non-Current Liabilities
Crispr Therapeutics Ag · Total Non-Current Liabilities
CRSP Total Non-Current Liabilities
Latest reported$194.31Mperiod ending
CRSP FY Total Non-Current Liabilities ($85.00K → $194.31M)
Annual total non-current liabilities
High-resolution chart · PNG
CRSP total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 194,310,000 | |
| 222,172,000 | |
| 237,976,999 | |
| 246,470,999 | |
| 232,534,000 | |
| 69,473,000 | |
| 70,221,000 | |
| 69,075,000 | |
| 69,003,000 | |
| 90,118,000 | |
| 113,871,000 | |
| 84,999 |